These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36707869)

  • 41. APOE ε4-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer's disease.
    Kim H; Kim S; Cho B; Shin J; Kim J
    Transl Neurodegener; 2022 Oct; 11(1):45. PubMed ID: 36284363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
    Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
    Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
    Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Missing apolipoprotein E ε4 allele associated with nonamnestic Alzheimer's disease in a Tunisian population.
    Fray S; Achouri-Rassas A; Belal S; Messaoud T
    J Genet; 2022; 101():. PubMed ID: 36226340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population.
    Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA
    Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders.
    Smith JC; Lancaster MA; Nielson KA; Woodard JL; Seidenberg M; Durgerian S; Sakaie K; Rao SM
    Neuroimage; 2016 May; 131():102-12. PubMed ID: 26265157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
    Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
    Lewandowski CT; Maldonado Weng J; LaDu MJ
    Neurobiol Dis; 2020 Jun; 139():104811. PubMed ID: 32087290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology.
    Chemparathy A; Le Guen Y; Chen S; Lee EG; Leong L; Gorzynski JE; Jensen TD; Ferrasse A; Xu G; Xiang H; Belloy ME; Kasireddy N; Peña-Tauber A; Williams K; Stewart I; Talozzi L; Wingo TS; Lah JJ; Jayadev S; Hales CM; Peskind E; Child DD; Roeber S; Keene CD; Cong L; Ashley EA; Yu CE; Greicius MD
    Neuron; 2024 Apr; 112(7):1110-1116.e5. PubMed ID: 38301647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age, APOE and sex: Triad of risk of Alzheimer's disease.
    Riedel BC; Thompson PM; Brinton RD
    J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
    Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M
    Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of APOE
    Thierry M; Ponce J; Martà-Ariza M; Askenazi M; Faustin A; Leitner D; Pires G; Kanshin E; Drummond E; Ueberheide B; Wisniewski T
    Acta Neuropathol; 2024 May; 147(1):91. PubMed ID: 38772917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
    Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
    Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased Aβ
    Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
    Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
    Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer's Disease.
    Ravipati K; Chen Y; Manns JR
    Am J Alzheimers Dis Other Demen; 2022; 37():15333175211070912. PubMed ID: 35041557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.